Antithrombin III (CSL Behring)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntithrombin III (CSL Behring)
Drug Alias NameアンスロビンＰ500Kybernin P抗凝血酶III (CSL Behring)Antithrombin-III-alphaAnthrobin +[8] 
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor X inhibitorsThrombin inhibitorsAntithrombin-III replacements
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsDisseminated Intravascular CoagulationThrombosis
Global Approved IndicationsDisseminated Intravascular CoagulationThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1987/08/02
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsDisseminated Intravascular CoagulationThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AB02
Related LinksKEGG